Home
Terns Pharmaceuticals

Terns Pharmaceuticals Market Share Analysis for May 2026

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity.

Industry: N/A

Domainternspharma.com

Year Founded2017

Employees51 - 200

Annual Revenue$10M - $15M

Terns Pharmaceuticals

Terns Pharmaceuticals (including company regionals)

ternspharma.com

See more website traffic and engagement information

Terns Pharmaceuticals Revenue up to May 2026 is 10M - 15M

revenue generated by Terns Pharmaceuticals top domains

Terns Pharmaceuticals top domains revenue over 3 years

Revenue for Terns Pharmaceuticals top domains

ternspharma.com10M - 15M

See more with Sales Intelligence

Total visits to Terns Pharmaceuticals's top domains

Understand Terns Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ternspharma.com8.9K

See more with Sales Intelligence

Avg. visit duration in Terns Pharmaceuticals's top domains

Analyze Terns Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ternspharma.com00:00:43

See more with Sales Intelligence

Avg. pageviews on Terns Pharmaceuticals's top domains

See how Terns Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ternspharma.com1.99

See more with Sales Intelligence

Terns Pharmaceuticals top competitors by domain

Top similar sites in May 2026, ranked by their affinity

biopharmadive.comCompany NameBioPharma DiveEmployees51 - 200HQUnited States, Washington, WashingtonAnnual revenue$10M - $15MTotal visits176.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Terns Pharmaceuticals

These are the website technologies, by industry, used by Terns Pharmaceuticals top domains

Content Management System (3)

WordPress

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

More Technologies

10

See all

News & Signals from Terns Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTerns Pharmaceuticals Inc. had issues with possible breaches of fiduciary duty and other violations of law on Apr 1st '26.MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) - Ademi LLP is investigating Terns (NASDAQ: TERN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Merck.

NewsMerck KGaA is planning to acquire Terns Pharmaceuticals Inc. for $6.7B.Germany $296 billion life science giant Merck to buy United States clinical-stage biopharmaceutical company Terns Pharmaceuticals for $6.7 billion, founded in 2017 by Zhong Weidong, Randall L. Halcomb & Martijn Fenaux.

NewsTerns Pharmaceuticals Inc. is developing medicine for a type of leukemia.Terns is developing a medicine for a type of leukemia that analysts see as a multibillion-dollar drug that could eventually rival Novartis' Scemblix.